TrialPloS one2011

Phase I randomised clinical trial of an HIV-1(CN54), clade C, trimeric envelope vaccine candidate delivered vaginally.

David J Lewis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.